High-ranking EU Commission officials give latest update on device directive recast text
This article was originally published in Clinica
Executive Summary
The European Commission has already provided signposts as to the future content of the medical device directives recast in terms what aspects need updating and new subjects that will be addressed. Last week, at the Eucomed Medtech Forum in Brussels, those at the very heart of Europe’s forthcoming regulation decision-making on devices, European Commissioner John Dalli and director Jacqueline Minor, provided the very latest update to the 400-strong audience. Amanda Maxwell reports
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.